Clinical Trials Browser

Phase 2 × Enrolling by invitation × carfilzomib × Clear all

NCT03815279 2019-08-16

iStopMM

Phase 2 Enrolling by invitation

Smoldering Multiple Myeloma, Multiple Myeloma